Entity

Time filter

Source Type


Parlar A.I.,Ahi Evren Gogus Kalp Damar Cerrahisi Education and Research Hospital | Sayar U.,Ahi Evren Gogus Kalp Damar Cerrahisi Education and Research Hospital | Cevirme D.,Ahi Evren Gogus Kalp Damar Cerrahisi Education and Research Hospital | Yuruk M.A.,Ahi Evren Gogus Kalp Damar Cerrahisi Education and Research Hospital | Mataraci I.,Ahi Evren Gogus Kalp Damar Cerrahisi Education and Research Hospital
International Journal of Artificial Organs | Year: 2014

In patients with respiratory failure and impairment of the left ventricle, arteriovenous extracorporeal membrane oxygenation (ECMO) offers further therapeutic options. Systemic anticoagulation is mandatory and heparin is routinely administrated. However, repeated exposure to heparin may cause heparin-induced thrombocytopenia (HIT) and carries a risk of thrombotic mortality and morbidity. We present a patient who developed HIT during ECMO support and was treated successfully and safely by fondaparinux. Fondaparinux can be used for thromboembolic treatment or prophylaxis in a patient with HIT. © 2014 Wichtig Publishing. Source

Discover hidden collaborations